These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32281490)

  • 1. Semiparametric integrative interaction analysis for non-small-cell lung cancer.
    Li Y; Wang F; Li R; Sun Y
    Stat Methods Med Res; 2020 Oct; 29(10):2865-2880. PubMed ID: 32281490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
    Li Y; Li R; Lin C; Qin Y; Ma S
    Stat Med; 2019 Jul; 38(17):3221-3242. PubMed ID: 30993736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping group screening for detection of gene-gene interactions: application to gene expression profiles with survival trait.
    Wang JH; Chen YH
    BMC Bioinformatics; 2018 Sep; 19(1):335. PubMed ID: 30241463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Gene-Environment Interactions by Non-Parametric Kendall's Partial Correlation with Application to TCGA Ultrahigh-Dimensional Survival Genomic Data.
    Wang JH; Yang CT
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):225. PubMed ID: 36042165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
    Jeong HH; Leem S; Wee K; Sohn KA
    J Ovarian Res; 2015 Jul; 8():42. PubMed ID: 26138921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying gene-gene interactions using penalized tensor regression.
    Wu M; Huang J; Ma S
    Stat Med; 2018 Feb; 37(4):598-610. PubMed ID: 29034516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrative sparse boosting analysis of cancer genomic commonality and difference.
    Sun Y; Sun Z; Jiang Y; Li Y; Ma S
    Stat Methods Med Res; 2020 May; 29(5):1325-1337. PubMed ID: 31282286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer epigenetics and genetics.
    Risch A; Plass C
    Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
    Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
    Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping group screening for detection of gene-environment interactions with application to TCGA high-dimensional survival genomic data.
    Wang JH; Wang KH; Chen YH
    BMC Bioinformatics; 2022 May; 23(1):202. PubMed ID: 35637439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A penalized robust semiparametric approach for gene-environment interactions.
    Wu C; Shi X; Cui Y; Ma S
    Stat Med; 2015 Dec; 34(30):4016-30. PubMed ID: 26239060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cancer genomic markers via integrative sparse boosting.
    Huang Y; Huang J; Shia BC; Ma S
    Biostatistics; 2012 Jul; 13(3):509-22. PubMed ID: 22045909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cancer graph: a lung cancer property graph database in Neo4j.
    Tuck D
    BMC Res Notes; 2022 Feb; 15(1):45. PubMed ID: 35164854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction screening by Kendall's partial correlation for ultrahigh-dimensional data with survival trait.
    Wang JH; Chen YH
    Bioinformatics; 2020 May; 36(9):2763-2769. PubMed ID: 31926011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
    Singal G; Miller PG; Agarwala V; Li G; Kaushik G; Backenroth D; Gossai A; Frampton GM; Torres AZ; Lehnert EM; Bourque D; O'Connell C; Bowser B; Caron T; Baydur E; Seidl-Rathkopf K; Ivanov I; Alpha-Cobb G; Guria A; He J; Frank S; Nunnally AC; Bailey M; Jaskiw A; Feuchtbaum D; Nussbaum N; Abernethy AP; Miller VA
    JAMA; 2019 Apr; 321(14):1391-1399. PubMed ID: 30964529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating network structure in integrative analysis of cancer prognosis data.
    Liu J; Huang J; Ma S
    Genet Epidemiol; 2013 Feb; 37(2):173-83. PubMed ID: 23161517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust semiparametric gene-environment interaction analysis using sparse boosting.
    Wu M; Ma S
    Stat Med; 2019 Oct; 38(23):4625-4641. PubMed ID: 31359454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.